Churchill Launches the Fall Season with an Upsize.
Churchill Capital Corp. filed an amended S-1 this morning, increasing their deal size from $400 million to $450 million. There were no other additions or subtractions to the terms or management team, but it does appear that Mr. Balakrishnan Iyer had a birthday somewhere between today’s filing and the previous amendment on August 20th. He’s a Virgo y’all…Happy 62!
Additionally, Citigroup is still the only underwriter on the cover. Can they take down a SPAC that size themselves? Yeah, they can. However, another bank such as I-Bankers, will mostly likely be brought on to top off the 350 round lot shareholders needed to comply with NYSE listing standards.
All told, an upsize is a great way to start what is anticipated to a busy Fall Season. Full updated summary of terms below:
Churchill Capital Corp. Summary of Terms:
- Focus: Technology / Software
- Size: $450 million
- 100% held in trust ($10.00 per share)
- $10.00 unit comprised of one share of Class A Common Stock + 1/2 of one Warrant
- Warrant call for redemption threshold: equals or exceeds $18.00 (cash or cashless exercise)
- 24 months to complete an acquisition
- Limitation on Redemption Rights: 15%
- At-risk Capital: $13.5 million (13,500,000 warrants at $1.00)
- Underwriter fees: 2.0% + 3.5% deferred.
Citigroup is sole book-runner.
Paul, Weiss, Rifkind, Wharton & Garrison LLP and Winston & Strawn LLP are Issuer’s Counsel and Underwriter’s Counsel, respectively.
Blue Ocean (NASDAQ:BOCN) provided significantly more texture today in the presentation for its $275 million combination with Asian digital media group TNL Mediagene, which it expects to hit profitability in the second half of the year despite a slight shakeup in financing for the transaction. The first big update in the first investor deck is...
At the SPAC of Dawn A brand new market may have just opened up for space de-SPACs as NASA administrator Bill Nelson announced a shift in the agency’s $11 billion program for a mission to return samples from Mars. Rather than rely on the agency’s internal technologies that would be predicted to get a sample...
Overall deal flow between SPACs and biotech firms has slowed over the last year, but some pending FDA changes could breathe new life into particular business models within the space. In particular, the FDA has asked Congress as part of its 2025 Legislative Proposals to eliminate the interchangeability designation for biosimilar medications, claiming the existing...
At the SPAC of Dawn Ever since Digital World announced its combination with Trump Media (NASDAQ:DJT) back in October 2021, it was clear that SPACworld and the Trump show were set to be intertwined for quite some time. And, although not every headline has a bearing on the wider SPAC world, Trump Media’s post-close rise...
AltC (NYSE:ALCC) has reportedly been taking the pitch deck for its combination with nuclear fission firm Oklo on the road in recent weeks, which has generated the rare result of a SPAC trading significantly above its trust value still well before completing its deal. The SPAC has an estimated $10.59 per share in its trust...